Co — Diagnostics Annual Shareholder Meeting Lacks Quorum
Co-Diagnostics’ reconvened annual shareholder meeting on October 14, 2026, lacked a quorum; none of the proposals received approval. Earlier sessions on September 3, September 24 and September 30, 2026, also failed to achieve a quorum. The company ended the meeting without another adjournment. It intends to seek approv